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Abstract 
Background and aims: Vitamin D deficiency (25-hydroxyvitamin D  - VitDD) affects over one billion 
people worldwide. VitDD results in progression of osteoporosis as well as other conditions. Previous 
studies have shown high rates of VitDD in Pakistan despite appreciable levels of sunshine. However, 
none have assessed VitDD across all age groups, genders, incomes and locations to guide future 
strategies. Methods: Questionnaire and blood sampling among 4830 randomly selected citizens. 
Results: High levels of VitDD among all age groups, genders, income levels and locations. 53.5% had 
VitDD, 31.2% had insufficient Vitamin D and only 15.3% normal Vitamin D. Conclusion: High rates of 
VitDD in Pakistan despite high levels of sunshine and previous Food Acts asking for food fortification 
with Vitamin D. Public health strategies are needed to address high VitDD rates, including food 
fortification, i.e. nurture, alongside increasing exposure to sunlight, i.e. nature. This will involve all key 
stakeholder groups. 
 
Keywords: 25-hydroxyvitamin-D, epidemiology, food supplements, strategies, risk factors, Pakistan, 
Vitamin D deficiency 
 
Introduction 
 
It is believed that vitamin D (25-hydroxyvitamin D) deficiency (affects over one billion people 
worldwide (1, 2). However, VDD appears to be one of the most under-diagnosed and under-treated 
dietary insufficiencies (3-16). This includes Pakistan (1, 2, 17-21). Vitamin D deficiency  has been 
linked to the progression of osteoporosis and osteoporotic fractures arising from secondary 
hyperparathyroidism (1, 11, 16, 19, 22-29), and can also lead to rickets and osteomalacia (10, 12, 23, 
26, 30) as well as potentially myopathy, helping explain why patients with nonspecific musculoskeletal 
pain syndrome can be refractory to standard therapies (31-33). Recent studies also suggest vitamin D 
has a potential role as an immune modulator and tumour suppressor (6, 16, 29, 34-39), although 
others are less certain (40). Vitamin D may also help prevent a number of other conditions including 
rheumatoid arthritis, diabetes, coronary heart disease, metabolic syndrome, depression, multiple 
sclerosis, respiratory diseases and cognitive impairment as well as reduce all-cause mortality (1, 6, 
19, 29, 32, 41-49). In addition, Vitamin D deficiency appears to be associated with an increased risk 
of obesity (20, 50), and Vitamin D supplementation can ameliorate the clinical signs of patients with 
atopic dermatitis (51). However, others believe there is a less clear link between Vitamin D deficiency 
and cardiovascular diseases, multiple sclerosis, arterial hypertension or cognitive dysfunction (1, 38, 
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52). Nevertheless, it is important to address Vitamin D deficiency to reduce the occurrence of 
osteoporosis, including osteoporotic fractures, as well as rickets and osteomalacia.  
 
Overall, there are three main causes of Vitamin D (25-hydroxyvitamin D) deficiency including dietary 
insufficiency, problems with absorption as well as lack of exposure to sunlight. Age and the level of 
physical activity can also affect Vitamin D (25-hydroxyvitamin D) levels (29). This is reflected by body 
mass index (BMI), skin pigmentation, and environmental factors, i.e. latitude, altitude, and 
meteorological conditions, influencing circulating vitamin D levels (26, 29, 30). Exposure to sunlight is 
perhaps the most important factor (2, 20). However, sufficient intake of vitamin D and calcium in a 
SHUVRQ¶V GLHW FDQ DOVR SOD\ an appreciable role in the prevention and management of the 
consequences of Vitamin D deficiency including osteoporosis and reducing the subsequent 
occurrence of fractures (1, 10, 11, 16, 23, 25). Studies have suggested serum 25(OH)D levels greater 
than 30 ng/mL (75 nmol/L) may be necessary to maximize intestinal calcium absorption and stop 
secondary hyperparathyroidism-induced skeletal conditions (1, 33, 53).  
 
Whilst a number of studies of varying sizes have been undertaken in Pakistan to assess Vitamin D 
status (1, 17-21), there does appear to be a lack of published data on the extent of Vitamin D 
deficiency across all age groups, genders, income groups and dwellings, e.g. urban and rural 
locations. We are aware that Khan and colleagues and Iqbal and colleagues assessed the level of 
Vitamin D deficiency among different localities in Karachi (20, 21), and Sheikh and colleagues 
assessed VDD among adults in Karachi (1). However to the best of our knowledge, no one has 
assessed levels of Vitamin D deficiency among all age groups, genders, locations and income levels 
simultaneously. Consequently, the principal objective of this study is to estimate the prevalence of 
Vitamin D deficiency among asymptomatic patients in a representative sample in Pakistan and use 
findings to suggest potential future policies that key stakeholders in Pakistan could instigate to reduce 
the level of Vitamin D deficiency. This is because the prevention of osteoporosis as well as other non-
communicable diseases, including diabetes and cardiovascular diseases, are seen as high priority 
areas in Pakistan, and likely to be included in the forthcoming National Health Plan (54, 55). The 
secondary objective is to assess the potential relationship between serum calcium and phosphate 
with vitamin D deficiency.  
 
Materials and Methods 
 
This study involved three parts. 
 
The first part was questionnaire based, conducted from January 2010 to December 2012 at five cities 
(Lahore, Rawalpindi/Islamabad, Sialkot/Gujranwala, Abbotabad and Peshawar) in two provinces of 
Pakistan (Punjab and Khyber Pakhtonkhwe ± KPK). This incorporates almost 50% of the total 
population of Pakistan. 
 
Each city/town/village was further divided into a number of small compact areas called Enumeration 
Blocks (EBs) consisting of 200 to 250 households. The populations of the selected areas were further 
divided into clusters of homogeneous rich and poor, i.e. covering slum and urban areas as well as 
locations where richer families live, with a random sample of personnel subsequently included in the 
questionnaire survey.  To enhance the robustness of the findings, the survey instruments were 
developed and pre- tested in other locations than those included in the final sample; however, this 
data was not included in this study. Overall, a total 4815 people across all age groups, sexes and 
locations where included in the questionnaire. Selection was undertaken using the convenience 
sampling technique to ensure true randomisation. The only exclusion criterion was that patients were 
not currently suffering from any chronic diseases including attending clinics.  
 
The main topics covered in the questionnaire included the age, sex, household income levels and 
history of fractures. Similar patient characteristics were seen in the study of Sheikh and colleagues 
(1). All data was captured onto Excel spreadsheets to ascertain the extent of Vitamin D deficiency and 
its severity among the different sexes and ages in Pakistan. 
 
The second component of the study involved taking approximately 3-5 mls of blood from all the study 
subjects and collecting this in gel tubes to subsequently analyse their serum vitamin D levels. The 
serum was separated via centrifugation at 3,000 rpm for 5 minutes. The test principle was based on 
an Electro-chemiluminescence Immuno Assay (ECLIA). The body mass index (BMI) was calculated 
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as weight (Kg) divided by height (m) squared (56). The assay uses a vitamin D binding protein 
(VDBP) as the capture protein in the assay, which binds to vitamin D2 and vitamin D3 (25- 
K\GUR[\OYLWDPLQ7KHUHDJHQWVDQGNLWZHUHVWRUHGDQGXVHGDFFRUGLQJWRPDQXIDFWXUHU¶VLQVWUXFWLRQV
[Package insert for vitamin D total (25-Hydroxyvitamin D) quantitative determination - Roche 
Diagnostics GmbH, Sandhofer Strasse 116, D- 68305 Mannheim, July 2012]. All the results were 
analyzed using MS excel.  
 
Vitamin D deficiency was defined as serum 25-hydroxyvitamin-D levels < 20 ng/mL, with vitamin D 
insufficiency as 21-29 ng/mL and vitamin D sufficiency as 30 ng/mL or greater for children and adults 
(1, 15, 16, 57). 
 
The third component was a pilot study involving 173 volunteers sampled in hospitals and private 
clinics to assess their calcium and phosphorous level as well as a possible relation with vitamin D 
deficiency. The body mass index (BMI) of the volunteers was calculated based on their weight and 
height. The sampling of volunteers was opportunistic. The data was captured in Excel, with the Excel 
statistical package used to determine the standard deviation and the level of significance. A p value of 
<0.05 was used to demonstrate statistical significance. 
 
All studies were approved by board of studies of Sargodha University, Pakistan, with the study 
meeting the requirements of the declarations of Helsinki and conducted in accordance with the 
current Good Clinical Practice (58)  
 
Results 
 
There was appreciable levels of sunshine among all the five selected cities throughout the year (taken 
from: www.weatheronline.com; www.weather-and-climate.com; www.climate-zone.com): 
x Lahore: Mean temperature ± 24.3ºC; 3094 sunshine hours 
x Sialkot/Gujranwala: Mean temperature ± 21.1ºC; 3044 sunshine hours 
x Rawalpindi/Islamabad: Mean temperature ± 21.3ºC; 3050 sunshine hours 
x Abbotabad: Mean temperature ± 18.0ºC; 2044 sunshine hours 
x Peshawar: Mean temperature ± 22.7ºC; 3110 sunshine hours 
 
Table 1 contains details of the socioeconomic and health status of the 4830 subjects included in the 
blood sampling. A history of fractures was present in 398 subjects. In Punjab, 1252 males and 2299 
females were included and in KPK, 343 males and 936 females were included.  
 
Table 1: Socioeconomic and other parameters (n= 4830) and %s 
 
Male: 1595; Female: 3235 
Monthly Income (Rs) 
<15000 627 (13.0%) 
30000 1729 (35.8%) 
50000 - 99999 2076 (43.0%) 
100000 215 (4.4%) 
Above 100000 183 (3.8%) 
Self-Reported Health 
Good 3099 (64.2%) 
Fair 880 (18.2%) 
Poor 851 (17.6%) 
History of Fracture 
Yes 403 (8.3%) 
No 4427 (91.7%) 
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A total of 4830 subjects comprising 1595 males (33.02%) and 3235 (66.98%) females were analysed 
for their serum 25-hydroxyvitamin-D levels. Figure 1 depicts the percentage of subject in each age 
group with different levels of 25-hydroxyvitamin-D deficiency, whilst Table 2 gives the absolute levels.  
 
Figure 1 -  Prevalence (%) of vitamin D deficiency and its severity among different sexes and age 
groups in Pakistan 
 
 
 
NB: M = Male; F = Female 
 
 
Overall, there were similar proportions of women and men with vitamin D (25-hydroxyvitamin-D) 
deficiency (Tables 2 and 3). 
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Tables 2 and 3. Numbers and prevalence (%) of vitamin D deficiency and its severity among the 
different sexes and age groups in Pakistan 
 
Age (yrs) 
Total (Numbers of 
citizens) 
Deficient Insufficient Normal 
<20 ng/ml 20-30 ng/ml >30 ng/ml 
 
M F M F M F M F 
<20 40 86 27 62 12 21 1 3 
21-30 260 537 153 315 75 149 32 73 
31-40 363 692 202 365 110 223 51 104 
41-50 447 846 231 452 155 246 61 148 
51-60 400 867 230 396 101 306 69 165 
61-70 40 112 25 50 15 46 0 16 
Above 70 45 95 21 56 20 29 4 10 
Total 1595 3235 889 1696 488 1020 218 519 
 
Percentages 
Age (yrs) Deficient <20 ng/ml Insufficient 21-30 ng/ml Normal >30 ng/ml 
 
M F M F M F 
<20 67.5 72.1 30.0 24.4 2.5 3.5 
21-30 58.8 58.7 28.8 27.7 12.3 13.6 
31-40 55.6 52.7 30.3 32.2 14.0 15.0 
41-50 51.7 53.4 34.7 29.1 13.6 17.5 
51-60 57.5 45.7 25.3 35.3 17.3 19.0 
61-70 62.5 44.6 37.5 41.1 0.0 14.3 
Above 70 46.7 58.9 44.4 30.5 8.9 10.5 
 
NB: M = Male; F = Female 
 
There were typically similar characteristics when the figures were broken down for the five cities 
(Appendix ± Tables A1 to A5) although some variations were noted (Figure 2). 
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Figure 2 ± The extent of Vitamin D deficiency by sex and city in Pakistan 
 
 
 
Table 4 contains the clinical characteristics of the 173 patients sampled in hospital with 156 
subsequently analyzed for serum calcium, phosphate and PTH concentrations. No significant 
differences were found and consequently, the findings were not taken further. 
 
Table 4 - Clinical characteristics among the 173 patients sampled in asymptomatic subjects with 
varying serum 25 OHD levels 
 
Variables Serum 25 OHD levels 
 Insufficient 
;ч20-30 ng/l) 
Sufficient 
(>30 ng/ml) 
Normal Value P-value 
 (n=156)  (n=17)   
Age group (years)     
Gender     
           Male (n=47)     
           Female (n=129)     
Body mass index (kg/m2) 21.12 +/-2.26 22.83 +/- 1.98 18.5-24.9 kg/m2 0.84 
     
Serum corrected calcium 
(mmol/L) 
2.18 +/- 0.68 2.24 +/ 0.24 2.15ʹ2.5 mmol/L 0.25 
Serum iPTH levels (ng/L) 78.24 +/ -24.12 62.82 +/ -
18.75 
16ʹ87 ng/L 0.82 
Alkaline phosphatase 
(ng/L) 
72.24 +/- 10.82 68.18 +/ -
12.76 
female: 29ʹ132 IU/L 
male: 28ʹ124 IU/L 
0.18 
Phosphorus (mg/dL) 3.22 +/- 1.24 3.12 +/ 1.69 2.7ʹ4. 9 mg/dL 0.26 
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Discussion 
 
We believe this is one of the largest studies conducted in Pakistan to assess 25-hydroxyvitamin D 
levels among an asymptomatic population taken from almost 50% of the Pakistan population. This 
complements the studies of Iqbal and colleagues, Sheikh and colleagues DVZHOODV3DNLVWDQ¶V
Nutritional Survey in 2011 (1, 20, 21). 
 
A high prevalence of vitamin D deficiency was recorded with 53.5% of citizens sampled having 
Vitamin D deficiency, 31.2% having insufficient Vitamin D and only 15.3% having normal Vitamin D 
(25-hydroxyvitamin D) levels (Figure 1, Tables 2 and 3). This appears irrespective of gender, age, 
location and income with only a minority of patients having a monthly income of RS10,000 or above 
with just under 50% having an income RS3000 or less (Figures 1 and 2, Tables 1 to 3 and A1 to A5). 
High rates of Vitamin D deficiency were also seen irrespective of the different levels of sunshine 
among the five city locations. 
 
The high rates of Vitamin D deficiency seen in our study are similar to previous studies conducted in 
Pakistan and in the neighbouring countries, as well as studies of Pakistani women conducted in other 
countries (1, 13, 14, 17-21, 26, 59-62). A high level of Vitamin D deficiency (40%) was also noted 
among children in the 2011 National Nutrition Survey with limited differences between urban and rural 
areas, although differences were seen at the provincial level (63). Other authors have shown though 
higher rates of VDD in postmenopausal women living in town houses and apartments versus those 
living in small and large bungalows, with similar findings among Saudi Arabian women (20, 64). This 
was not seen in our study. Other authors have also shown higher prevalence in lower income groups 
(65). This may be due to differences in sampling or other techniques used. In addition, only a minority 
of households in our study earned RS10,000 per month or above and we did not break the figures 
down further into the various income groups outlined in Table 1. 
 
In any event, there is an urgent need to address current high levels of Vitamin D deficiency among the 
population in Pakistan. Strategies to address this can be divided into nature, e.g. aspects such as 
sunlight, and nurture, e.g. Vitamin D supplementation. This is because personal, social, and cultural 
factors are important determinants of Vitamin D availability via their effects on sun exposure to 
ultraviolet light (UVB) and adequate intake from diet or supplements (2, 20, 26, 29, 66). Pakistan is 
DPRQJWKHZRUOG¶VPRVWVXQULFKFRXQWULHV, with the cutaneous production of Vitamin D possible 
throughout the year (2). However, town dwellers may well be subject to Vitamin D deficiency  due to 
air pollutants (67, 68), with for instance Karachi ranked as one of the most polluted cities reflected by 
multi pollutant indices (69). This may help explain why a higher incidence of Vitamin D deficiency was 
found among postmenopausal women dwelling in town houses and apartments in Karachi versus 
those living in bungalows in the suburbs (20), as well more densely versus less densely populated 
areas of Karachi in the study by Iqbal and colleagues (21). However, this cannot be the only 
explanation with high levels of vitamin D deficiency seen across both urban and rural areas in our 
study and across all age groups. Chronic and acute malnutrition in a country is one of the primary 
reasons for Vitamin D deficiency, i.e. attributable to poverty, high illiteracy rates among mothers and 
food insecurity (15, 16). Generally natural food sources have low vitamin D content and consequently 
require fortification where Vitamin D deficiency rates are high (26). This is especially important in 
countries where a population has limited knowledge of the level of Vitamin D in foodstuffs as seen in 
Pakistan (Personal communication Shahazad Hussain).  
 
Vitamin D supplements can be given to prevent Vitamin D deficiency in Pakistan, building on existing 
appreciable self purchasing of bisphosphonates in Pakistan to prevent fractures in patients with 
osteoporosis (54). The Institute of Medicine's current recommended intake of vitamin D is 15 
micrograms (600 IU) up to age 70 and 20 micrograms (800 IU) after 70 (1, 70).  
 
Overall, a thorough understanding of the association of these factors is important given the extent of 
Vitamin D deficiency in Pakistan highlighted in our study as well as those of others (1, 17, 18, 20, 21). 
The Pakistan Food Act of 1965 states that all fats and oils produced in Pakistan should be fortified 
with Vitamin D (20). However, this is typically not enforced, with currently no labels on these food 
stuffs indicating any fortification. Presently, there are also no recommended guidelines to address 
VDD in Pakistan (1). However, this may change with the forthcoming Pakistan National Health Plan 
aimed at combating high priority non-communicable diseases including cardiovascular diseases and 
osteoporosis (54, 55, 71).  
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In view of the demonstrated prevalence of Vitamin D deficiency in Pakistan across all age groups in 
our study, it is suggested that policy makers urgently develop initiatives to address this (53). These 
could include firstly strategies involving education and food fortification programs with vitamin D, 
building on the 1965 Food Act. Secondly, encouraging the ingestion of vitamin D supplements when 
needed (66). This builds on patient concerns regarding the development of osteoporosis, 
demonstrated by the current extent of self-purchasing of bisphosphonates and Vitamin D in Pakistan 
(54), i.e. nurture. Thirdly, increasing citizen exposure to sunlight, i.e. nature, given the extent of 
sunlight in Pakistan. This is because Asians living in Pakistan typically have serum 25-
hydroxycholecalciferol concentrations well within the normal range (72). This could be achieved 
through for instance involving religious leaders, who in their sermons on Fridays could emphasize the 
importance of vitamin D deficiency. Initially emphasising diet; however in the longer term reviewing 
issues such as dress in public since there are limited opportunities for private sub exposure among 
dwellings in Pakistan. This builds on successful strategies involving religious leaders to help eradicate 
polio through immunisation programmes.  
 
Future Public Health strategies to reduce appreciable levels of Vitamin D deficiency in Pakistan 
should also involve all key stakeholder groups working together.  This includes government 
personnel, physicians including those involved with Medical Colleges, clinical pharmacologists and 
pertinent patient organisations working alongside religious leaders to urgently address the current 
rates of Vitamin D deficiency in Pakistan. A number of Western countries have Vitamin D food 
fortification policies (73), serving as an example. Consequently, Pakistan could follow this lead as well 
as include other strategies in their forthcoming National Health Plan to appreciably reduce the extent 
of Vitamin D deficiency and its consequences on morbidity and mortality. We will monitor the situation 
in future research projects. 
 
We acknowledge that there are a number of weaknesses with our research. These include the fact 
that appreciably more women were recruited than men due to the sampling technique used. Typically, 
the ratio of men to women in Pakistan is just over 1. We also did not ask questions about current 
Vitamin D supplementation. Nevertheless, we believe our study is valid and provides a good insight 
into the current extent of Vitamin D deficiency in Pakistan and potential ways forward.  
 
In conclusion, we believe we have demonstrated that there are appreciable levels of Vitamin D 
deficiency among all age groups, genders, income levels and locations in Pakistan. This is despite 
high levels of sunlight throughout the year. A number of strategies have been identified to address 
this concern including following up previous Food Acts in the forthcoming Pakistan National Health 
Plan. We will monitor these in future research projects. 
 
Key Issues 
 
x Vitamin D deficiency (VDD) is a prevalent condition affecting over one billion people worldwide, 
and appears to be one of the most under-diagnosed and under-treated dietary insufficiencies  
 
x VDD has been linked to the progression of osteoporosis and osteoporotic fractures arising from 
secondary hyperparathyroidism as well as a variety of other conditions. Consequently, VDD 
needs to be addressed 
 
x Previous studies have shown high rates of VDD in Pakistan despite appreciable levels of 
sunshine across cities and regions, and previous Food Acts asking for food fortification with 
Vitamin D. However to date, no published appears to have assessed VDD across all age groups, 
genders, incomes and locations in Pakistan to guide future strategies.  
 
x Our findings demonstrated high levels of VDD among all age groups, genders, income levels and 
locations in Pakistan. 38% of patients sampled had severe VDD, 29% moderate VDD and 25% 
mild VDD using our definitions, with only 8.6% normal Vitamin D levels.  
 
x These findings have considerable implications for the future morbidity and mortality of citizens in 
Pakistan as well as costs. 
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x Public health strategies are needed to address high VDD rates. These include food fortification, 
i.e. nurture, alongside increasing exposure to sunlight, i.e. nature, involving all key stakeholder 
groups including religious leaders. 
 
x Religious leaders in their sermons on Fridays could emphasize the importance of vitamin D 
deficiency. Initially emphasising diet; however in the longer term reviewing issues such as dress 
in public with limited opportunities for exposure in private to overcome high levels of moderate to 
severe VDD in Pakistan 
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Supplementary Tables (Appendix) 
 
 
Table A1: Vitamin D deficiency and its severity in males and females in Lahore  
 
 
Lahore (Citizen numbers) 
Age (yrs) Total 
Deficient Insufficient Normal 
<20 ng/ml 21-30 ng/ml >30 ng/ml 
 
M F M F M F M F 
<20 13 23 9 15 3 6 1 2 
21-30 91 197 59 132 23 34 9 31 
31-40 109 197 79 143 20 38 10 16 
41-50 118 284 77 216 28 46 13 22 
51-60 84 333 57 136 18 132 9 65 
61-70 14 18 9 15 5 3 0 0 
Above 70 7 13 7 13 0 0 0 0 
Total 436 1065 297 670 97 259 42 136 
NB: M = Male; F = Female 
 
 
Lahore % 
Age (yrs) Deficient <20 ng/ml Insufficient 21-30 ng/ml Normal >30 ng/ml 
 
M F M F M F 
<20 69.2 65.2 23.1 26.1 7.7 8.7 
21-30 64.8 67.0 25.3 17.3 9.9 15.7 
31-40 72.5 72.6 18.3 19.3 9.2 8.1 
41-50 65.3 76.1 23.7 16.2 11.0 7.7 
51-60 67.9 40.8 21.4 39.6 10.7 19.5 
61-70 64.3 83.3 35.7 16.7 0.0 0.0 
Above 70 100.0 100.0 0.0 0.0 0.0 0.0 
Total 68.1 62.9 22.2 24.3 9.6 12.8 
NB: M = Male; F = Female 
 
Table A2: Vitamin D deficiency and its severity in males and females in Sialkot/Gujranwala (RWP/ISB) 
 
 
SKT/GWA (Patient numbers) 
Ages (yrs) Total 
Deficient Insufficient Normal 
<20 ng/ml 21-30 ng/ml >30 ng/ml 
 
M F M F M F M F 
<20 5 13 3 12 2 1 0 0 
21-30 29 44 21 32 6 10 2 2 
31-40 70 111 48 71 14 34 8 6 
41-50 173 187 82 114 65 35 26 38 
51-60 112 252 61 128 25 74 26 50 
61-70 3 5 2 3 1 2 0 0 
Above 70 1 3 1 3 0 0 0 0 
Total 393 615 218 363 113 156 62 96 
NB: M = Male; F = Female 
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SKT/GWA % 
   
Age (yrs) 
Deficient Insufficient Normal 
<20 ng/ml 21-30 ng/ml >30 ng/ml 
 
M F M F M F 
<20 60.0 92.3 40.0 7.7 0.0 0.0 
21-30 72.4 72.7 20.7 22.7 6.9 4.5 
31-40 68.6 64.0 20.0 30.6 11.4 5.4 
41-50 47.4 61.0 37.6 18.7 15.0 20.3 
51-60 54.5 50.8 22.3 29.4 23.2 19.8 
61-70 66.7 60.0 33.3 40.0 0.0 0.0 
Above 70 100.0 100.0 0.0 0.0 0.0 0.0 
Total 55.5 59.0 28.8 25.4 15.8 15.6 
NB: M = Male; F = Female 
 
Table A3: Vitamin D deficiency and its severity in males and females in Islamabad/Rawalpindi 
(RWP/ISB) 
 
   
RWP/ISB (Citizen numbers) 
   
Age (yrs) Total 
Deficient Insufficient Normal 
<20 ng/ml 20-30 ng/ml >30 ng/ml 
 
M F M F M F M F 
<20 5 19 3 15 2 4 0 0 
21-30 66 112 39 63 20 34 7 15 
31-40 111 148 56 82 41 46 14 20 
41-50 101 150 49 62 41 57 11 31 
51-60 126 166 86 94 31 49 9 23 
61-70 7 13 5 11 2 2 0 0 
Above 70 7 11 7 8 0 3 0 0 
Total 423 619 245 335 137 195 41 89 
NB: M = Male; F = Female 
 
 
RWP/ISB % 
   
Age (yrs) 
Deficient Insufficient Normal 
<20 ng/ml 21-30 ng/ml >30 ng/ml 
 
M F M F M F 
<20 60.0 78.9 40.0 21.1 0.0 0.0 
21-30 59.1 56.3 30.3 30.4 10.6 13.4 
31-40 50.5 55.4 36.9 31.1 12.6 13.5 
41-50 48.5 41.3 40.6 38.0 10.9 20.7 
51-60 68.3 56.6 24.6 29.5 7.1 13.9 
61-70 71.4 84.6 28.6 15.4 0.0 0.0 
Above 70 100.0 72.7 0.0 27.3 0.0 0.0 
Total 57.9 54.1 32.4 31.5 9.7 14.4 
NB: M = Male; F = Female 
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Table A4: Vitamin D deficiency and its severity in males and females in Abbotabad (ABD) 
 
   
ABD (Citizen numbers) 
   
Age (yrs) Total 
Deficient Insufficient Normal 
<20 ng/ml 20-30 ng/ml >30 ng/ml 
 
M F M F M F M F 
<20 4 7 4 4 0 2 0 1 
21-30 26 31 13 19 7 11 6 1 
31-40 21 38 7 22 11 12 3 4 
41-50 13 33 5 19 7 6 1 8 
51-60 36 42 14 13 12 19 10 10 
61-70 4 20 3 12 1 5 0 3 
Above 70 3 13 1 7 2 3 0 3 
Total 107 184 47 96 40 58 20 30 
NB: M = Male; F = Female 
 
 
ABD % 
   
Age (yrs) 
Deficient Insufficient Normal 
<20 ng/ml 21-30 ng/ml >30 ng/ml 
 
M F M F M F 
<20 100.0 57.1 0.0 28.6 0.0 14.3 
21-30 50.0 61.3 26.9 35.5 23.1 3.2 
31-40 33.3 57.9 52.4 31.6 14.3 10.5 
41-50 38.5 57.6 53.8 18.2 7.7 24.2 
51-60 38.9 31.0 33.3 45.2 27.8 23.8 
61-70 75.0 60.0 25.0 25.0 0.0 15.0 
Above 70 33.3 53.8 66.7 23.1 0.0 23.1 
Total 43.9 52.2 37.4 31.5 18.7 16.3 
NB: M = Male; F = Female 
 
Table A5:  Vitamin D deficiency and its severity in males and females in Peshawar (PWR) 
 
   
PWR 
   
Age (yrs) Total 
Deficient Insufficient Normal 
<20 ng/ml 20-30 ng/ml >30 ng/ml 
 
M F M F M F M F 
<20 13 24 8 16 5 8 0 0 
21-30 48 153 21 69 19 60 8 24 
31-40 52 198 12 47 24 93 16 58 
41-50 42 192 18 41 14 102 10 49 
51-60 42 74 12 25 15 32 15 17 
61-70 12 56 6 9 6 34 0 13 
Above 70 27 55 5 25 18 23 4 7 
Total 236 752 82 232 101 352 53 168 
NB: M = Male; F = Female 
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PWR % 
   
Age (yrs) 
Deficient Insufficient Normal 
<20 ng/ml 21-30 ng/ml >30 ng/ml 
 
M F M F M F 
<20 61.5 66.7 38.5 33.3 0.0 0.0 
21-30 43.8 45.1 39.6 39.2 16.7 15.7 
31-40 23.1 23.7 46.2 47.0 30.8 29.3 
41-50 42.9 21.4 33.3 53.1 23.8 25.5 
51-60 28.6 33.8 35.7 43.2 35.7 23.0 
61-70 50.0 16.1 50.0 60.7 0.0 23.2 
Above 70 18.5 45.5 66.7 41.8 14.8 12.7 
Total 34.7 30.9 42.8 46.8 22.5 22.3 
NB: M = Male; F = Female 
 
 
